These findings underscore the need for future studies examining the role of non-BRCA1/2 genes in SBC and CBC to help inform the complex decision-making process that physicians and patients must navigate when results of multigene panel testing are returned for a patient with a new breast cancer. Here, BRCA1 is linked to breast cancer.